Robotic Liquid Handling System Supply

The contract involves the supply of a new robotic liquid handling system designed to automate critical steps in genomic workflows, specifically DNA shearing and AMPure bead cleanup, with seamless integration into the PacBio Sequel IIe long-read sequencing platform. This system aims to enhance throughput, precision, and reproducibility in sample preparation, reducing manual intervention and potential variability in downstream sequencing data. The equipment must meet stringent performance and compatibility standards to ensure reliable operation within the FDA’s research and diagnostics environment, with a focus on scalability and error-reduction in high-volume settings. The solicitation is issued as a subcontract under the Department of Health and Human Services, specifically managed by the FDA Office of Acquisition and Grant Services, with a mandatory response deadline of August 12, 2026. The place of performance is designated as Laurel, Maryland, 20708, indicating that installation, validation, and possibly training will occur on-site at a federal facility. The NAICS code 333318 classifies this as a medical and diagnostic laboratory equipment manufacturing contract, underscoring the technical sophistication required. No set-aside provisions are specified, and bidders must be prepared to deliver a fully integrated, validated system capable of meeting federal research compliance standards without delay.